Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Varie
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Equity Briefing: Upgrades and Downgrades for July 20th: NUE, NXTM, ONXX, ORB…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: Nomura reiterated its buy rating on shares of Nucor Co. (NYSE: NUE). They noted that the move was a valuation call. ThinkEquity initiated coverage on shares of Nxstage Medical (NASDAQ: NXTM). They issued a buy rating on the stock. Leerink Swann upgraded shares of Onyx Pharmaceuticals, Inc...
Thomson Reuters
20/07/2012
Equity Briefing: Upgrades and Downgrades for July 20th: KITD, KOF, KOG, LHO…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: Canaccord Genuity initiated coverage on shares of Kit Digital Inc (NASDAQ: KITD). They issued a hold rating on the stock. Citigroup initiated coverage on shares of Coca-Cola FEMSA (NYSE: KOF). They issued a neutral rating on the stock. Capital One downgraded shares of Kodiak Oil & Gas Corp...
Thomson Reuters
20/07/2012
Equity Briefing: Upgrades and Downgrades for July 20th: CY, DGX, EBAY, END…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: Nomura reiterated its buy rating on shares of Cypress Semi (NYSE: CY). RBC Capital downgraded shares of Quest Diagnostics Inc (NYSE: DGX) from an outperform rating to a sector perform rating. JPMorgan Chase upgraded shares of eBay, Inc. (NASDAQ: EBAY) from a neutral rating to an overweight rating...
Thomson Reuters
20/07/2012
Equity Briefing: Upgrades and Downgrades for July 20th: ADK, AF, AHT, AKZOY…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: C.K. Cooper initiated coverage on shares of Adcare Health System (NYSE: ADK). They issued a buy rating on the stock and set a $6.50 price target. Stifel Nicolaus downgraded shares of Astoria Financial Co. (NYSE: AF) from a hold rating to a sell rating. SunTrust initiated coverage on shares of Ashford Hospitality Trust (NYSE: AHT)...
Thomson Reuters
20/07/2012
Equity Briefing: Upgrades and Downgrades for July 19th: VZ
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: Nomura reiterated its neutral rating on shares of Verizon (NYSE: VZ). Stay on top of analysts' coverage with Analyst Ratings Network's free daily email newsletter that provides a concise list of analysts' upgrades, downgrades and initiations. Register at http://bit...
Thomson Reuters
20/07/2012
Equity Briefing: Upgrades and Downgrades for July 19th: ABT, CYS, EQIX, EQR…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: UBS AG raised its price target on shares of Abbott Laboratories (NYSE: ABT) from $68.00 to $72.00. They have a buy rating on the stock. Ladenburg Thalmann downgraded shares of Cypress Sharpridge Investments, Inc. (NYSE: CYS) from a buy rating to a neutral rating. Nomura initiated coverage on shares of Equinix, Inc. (NASDAQ: EQIX)...
Thomson Reuters
20/07/2012
£200,000 Up for Grabs on This Weekend's totescoop6
Last weekend's anonymous syndicate landed the bonus of £318,933 after Bonnie Brae landed the Bunbury Cup taking their total winnings to just under £500,000.
PR Newswire
20/07/2012
Horizon Pharma Moving Ahead of FDA Decision
By Brian Wilson, Contributor Shares of the pain drug developer Horizon Pharma (NASDAQ:HZNP) have recently seen some huge moves to the upside as the FDA's decision looms for the company's rheumatoid arthritis treatment RAYOS gets closer. Even after a virtual doubling of the shares since June, the company is valued at modest $265 million. The two major firms that cover the stock (Stifel Nicolaus and JMP Securities) have price targets that exceed the current price of $7...
Thomson Reuters
20/07/2012
MarketsandMarkets: Global Modified Starch Market worth $15.23 Billion by 2017
Browse more than 120 market data tables spread through
PR Newswire
20/07/2012
Doctors Beat F1 Drivers in Public's Perception of Professions
In an analysis[1] of perception of different professions, one in three Brits (33.3%) believe doctors have the highest degree of skill compared to other professions. One in four (24.4%) also think that being a doctor requires the greatest degree of continuous focus. However, only one in ten people (9.9%) feel that being a doctor requires the greatest degree of natural talent. Actors come out on top in the talent stakes with one in five (20.3%) Brits believing they are the profession with the most…
PR Newswire
20/07/2012
Change in the ownership of Kesko Corporation's own shares
KESKO CORPORATION STOCK EXCHANGE NOTIFICATION 20.07.2012 AT 09.00 1(1) 476 B shares (KESBV) have been returned to Kesko Corporation without consideration in accordance with the terms of Kesko's three-year share-based compensation plan. The shares were initially transferred to a person in the target group of the share-based compensation plan's 2011 vesting period. After the return of the shares, Kesko holds 607,725 own B shares...
Thomson Reuters
20/07/2012
Equity Briefing: Pluristem Therapeutics' Peripheral Artery Treatment Likely to…
Peripheral artery disease (PAD), long known as a silent killer that often goes undiagnosed past the point for effective control and treatment, is a medical market coming into its own. While drugs for heart disease have taken center stage for decades, PAD, intimately linked to coronary and carotid vascular build-up, is finally being recognized by big pharmaceutical players...
Thomson Reuters
20/07/2012
Equity Briefing: Earnings Results for July 19th: SWY, SYNT, TCB, TRV, TSM, TXT…
A number of companies released their quarterly earnings results today, as reported by Analyst Ratings Network and Equity Briefing: Safeway (SWY) released its earnings data on Thursday. The company reported $0.50 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.48 by $0.02. The company's quarterly revenue was up 1.8% on a year-over-year basis. Syntel (SYNT) released its earnings data on Thursday. The company reported $1...
Thomson Reuters
19/07/2012
Equity Briefing: Earnings Results for July 19th: KEY, KNL, LH, LTM, LUV, MS…
A number of companies released their quarterly earnings results today, as reported by Analyst Ratings Network and Equity Briefing: KeyBanc (KEY) announced its earnings results on Thursday. The company reported $0.23 earnings per share for the quarter, beating the analysts' consensus estimate of $0.18 by $0.05. The company's quarterly revenue was up .5% on a year-over-year basis. Knoll (KNL) posted its quarterly earnings results on Thursday. The company reported $0...
Thomson Reuters
19/07/2012
Equity Briefing: Earnings Results for July 19th: ADS, AN, ARB, BAX, BBT, BX…
A number of companies released their quarterly earnings results today, as reported by Analyst Ratings Network and Equity Briefing: Alliance Data Systems (ADS) issued its quarterly earnings data on Thursday. The company reported $2.13 earnings per share for the quarter, beating the analysts' consensus estimate of $1.91 by $0.22. Alliance Data Systems's revenue was up 17.0% compared to the same quarter last year. Autonation (AN) issued its quarterly earnings data on Thursday...
Thomson Reuters
19/07/2012
Equity Briefing: Earnings Results for July 18th: PTP, QCOM, RLI, SCSS, SEIC…
A number of companies released their quarterly earnings results today, as reported by Analyst Ratings Network and Equity Briefing: Platinum Underwriter (PTP) announced its earnings results on Wednesday. The company reported $1.97 earnings per share for the quarter, beating the analysts' consensus estimate of $1.18 by $0.79. Platinum Underwriter's revenue was down 15.8% compared to the same quarter last year. QUALCOMM (QCOM) announced its earnings results on Wednesday...
Thomson Reuters
19/07/2012
Equity Briefing: Earnings Results for July 18th: EGHT, ERIC, EWBC, FCFS, FFIV…
A number of companies released their quarterly earnings results today, as reported by Analyst Ratings Network and Equity Briefing: 8x8 (EGHT) released its earnings data on Wednesday. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.01. The company's revenue for the quarter was up 36.8% on a year- over-year basis. Telefonaktiebolaget LM Ericsson (ERIC) released its earnings data on Wednesday...
Thomson Reuters
19/07/2012
Equity Briefing: Earnings Results for July 18th: ABT, AF, AOS, APH, ASML, AXP…
A number of companies released their quarterly earnings results today, as reported by Analyst Ratings Network and Equity Briefing: Abbott Laboratories (ABT) released its earnings data on Wednesday. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The company's revenue for the quarter was up 2.0% on a year-over-year basis. Astoria Financial (AF) released its earnings data on Wednesday...
Thomson Reuters
19/07/2012
Equity Briefing: Upgrades and Downgrades for July 19th: THRX, USB
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: Sanford C. Bernstein downgraded shares of Theravance, Inc. (NASDAQ: THRX) from an outperform rating to a market perform rating. Oppenheimer downgraded shares of US Bancorp (NYSE: USB) from an outperform rating to a market perform rating. Argus downgraded shares of Xcel Energy Inc. (NYSE: XEL) from a buy rating to a hold rating...
Thomson Reuters
19/07/2012
Equity Briefing: Upgrades and Downgrades for July 19th: ORBT, PACW, PCCC, PEG…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: C.K. Cooper initiated coverage on shares of Orbit International Corp. (NASDAQ: ORBT). They issued a hold rating on the stock. Keefe, Bruyette & Woods downgraded shares of PacWest Bancorp (NASDAQ: PACW) from an outperform rating to a market perform rating. Roth Capital initiated coverage on shares of Pc Connection Inc...
Thomson Reuters
19/07/2012
Equity Briefing: Upgrades and Downgrades for July 19th: DOV, DSW, EWBC, FE, GPL…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: William Blair upgraded shares of Dover Co. (NYSE: DOV) from a market perform rating to an outperform rating. Benchmark Co. initiated coverage on shares of DSW Inc. (NYSE: DSW). They issued a hold rating on the stock and set a $60.00 price target...
Thomson Reuters
19/07/2012
Equity Briefing: Upgrades and Downgrades for July 19th: AIRM, ANR, AOS, ARRS…
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network and Equity Briefing: Stephens downgraded shares of Air Methods Corp (NASDAQ: AIRM) from an overweight rating to an equal weight rating. Brean Murray downgraded shares of Alpha Natural Resources (NYSE: ANR) from a buy rating to a hold rating. Sterne Agee downgraded shares of A.O. Smith (NYSE: AOS) from a buy rating to a neutral rating...
Thomson Reuters
19/07/2012
Trade Catalyst: Verisante Readies Commercial Launch of Innovative Skin Cancer…
There is a growing epidemic of skin cancer and one emerging medical device firm is poised to capture a big market position and visibility as they prepare to launch a device which addresses this growing need. Skin cancer is one of the world's most common cancers, and growing. According to experts, more than 3...
Thomson Reuters
19/07/2012
Analyst Sees Neptune As Strong Buy; Issues New $9.25 Price Target
Shares of Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) (TSX:NTB) are in the spotlight following an updated research report by Robin Cornwell of Catalyst Research. In the note, Cornwell increased his 12 month price target to $9.25 from $8.75. After recent fundamental developments announced by the company, the research firm revised their fiscal 2013 and 2014 forecasts and introduced new fiscal 2015 projections...
Thomson Reuters
19/07/2012
Altri Comunicati